Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9044467 | 0.82 | NPC1 (0.38) | EPHX2LIPGNPC1CYP2D6CYP2C19 | |
| SCHEMBL9035539 | 0.81 | NPC1 (0.30) | NPC1 | |
| SCHEMBL27888454 | 0.81 | EPHX2 (0.46) | EPHX2LIPGNPC1 | |
| SCHEMBL27364774 | 0.81 | EPHX2 (0.37) | EPHX2LIPGNPC1 | |
| SCHEMBL27381737 | 0.81 | EPHX2 (0.40) | EPHX2LIPGNPC1CYP2D6CYP2C19 | |
| SCHEMBL27013893 | 0.78 | NPC1 (0.43) | EPHX2NPC1CYP2D6CYP2C19 | |
| SCHEMBL27536365 | 0.77 | EPHX2 (0.41) | EPHX2LIPGNPC1 | |
| SCHEMBL11233022 | 0.75 | NPC1 (0.47) | EPHX2LIPGNPC1 | |
| SCHEMBL1291849 | 0.75 | NPC1 (0.47) | EPHX2LIPGNPC1 | |
| SCHEMBL7074067 | 0.75 | NPC1 (0.47) | EPHX2LIPGNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0450066-B1 | CARBOSTYRIL DERIVATIVES | OTSUKA PHARMA CO LTD (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5227381-A | Anticoagulant | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-13 | — | — | US | disclosed |
| EP-0450066-A1 | CARBOSTYRIL DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-10-09 | — | — | EP | disclosed |